Health Condition 1: K769- Liver disease, unspecified Health Condition 2: K758- Other specified inflammatory liverdiseases
Conditions
Interventions
Intervention1: NIL: NIL
Sponsors
Hasbiya
Eligibility
Inclusion criteria
Inclusion criteria: Patients diagnosed with acute liver failure, alcoholic fatty liver disease, non alcoholic fatty liver disease, alcoholic hepatitis, hepatic abscesses, hepatitis A, B, C, Cirrhosis, hepatic encephalopathy, cholestasis, liver cancer, cholangitis and infection associated with liver diseases like bacteremia, pneumonia, urinary tract infection, spontaneous bacterial peritonitis, endocarditis who are admitted to inpatient department.
Exclusion criteria
Exclusion criteria: Patients below the age group of 18 years, Patients who are unresponsive, unconscious and comatose ,Patients admitted due to psychiatric conditions, Patients who are not willing to participate in the study, Pregnant and lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The study results will give an overview of the prevalence and specific bacterial strain associated with liver disease. The outcome will result in better diagnosis, treatment and management strategies. Identification of specific bacterial strain will help in the development of targeted antimicrobial agent, addressing the unique challenges posed by infections in liver disease patients.Timepoint: 0 15 30 days | — |
Secondary
| Measure | Time frame |
|---|---|
| The study will provide current treatment modalities and reporting of adverse drug reactionTimepoint: 0 15 30 days | — |
Countries
India
Contacts
Public ContactDivya vc
Karavali college of pharmacy
Outcome results
None listed